{{Underlinked|date=May 2016}}
{{Drugbox
| verifiedrevid = 447613606
| IUPAC_name = ''N''-[2-(diethylamino)ethyl]-''N''-propylnaphthalene-1-carboxamide
| image = Bunaftine.svg

<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4  / S8 -->
| legal_UK = <!-- GSL         / P       / POM / CD -->
| legal_US = <!-- OTC                   / Rx-only  -->
| legal_status =  
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 32421-46-8
| ATC_prefix = C01
| ATC_suffix = BD03
| PubChem = 36131
| ChEMBL = 2104200
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 33233
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = GH09PRQ3FU
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07428

<!--Chemical data-->
| C=21 | H=30 | N=2 | O=1 
| molecular_weight = 326.476 g/mol
| smiles = O=C(N(CCCC)CCN(CC)CC)c2cccc1ccccc12
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C21H30N2O/c1-4-7-15-23(17-16-22(5-2)6-3)21(24)20-14-10-12-18-11-8-9-13-19(18)20/h8-14H,4-7,15-17H2,1-3H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = WWGZXRYELYWJBD-UHFFFAOYSA-N
}}

'''Bunaftine''' (or '''bunaphtine'''<ref name="pmid7436628">{{cite journal |author=Tamargo J |title=Electrophysiological effects of bunaphtine in guinea-pig ventricular fibers |journal=Arch Int Pharmacodyn Ther |volume=246 |issue=2 |pages=224–36 |date=August 1980 |pmid=7436628 |doi= |url=}}</ref>) is an [[antiarrhythmic agent]].<ref name="pmid6876382">{{cite journal |vauthors=Ferro G, Chiariello M, Tari MG, Vigorito C, Ungaro B, Condorelli M |title=Intropic effects of several antiarrhythmic drugs |journal=Jpn Heart J |volume=24 |issue=3 |pages=377–90 |date=May 1983 |pmid=6876382 |doi= 10.1536/ihj.24.377|url=}}</ref> It is classified in [[class III antiarrhythmic|class III]].<ref name="pmid328029">{{cite journal |vauthors=Fenici R, Marchei M, Bellocci F, Zecchi P |title=Effect of bunaphtine on right atrial repolarisation in man |journal=Br Heart J |volume=39 |issue=7 |pages=787–94 |date=July 1977 |pmid=328029 |pmc=483317 |doi= 10.1136/hrt.39.7.787|url=http://heart.bmj.com/cgi/pmidlookup?view=long&pmid=328029}}</ref>

==References==
{{reflist}}

{{Potassium channel blockers}}
{{Antiarrhythmic agents}}

[[Category:Antiarrhythmic agents]]
[[Category:Potassium channel blockers]]
[[Category:Naphthalenes]]
[[Category:Carboxamides]]


{{cardiovascular-drug-stub}}